This book describes exposure, infection, disease, and death from TB using epidemiological data. It reviews statistics, including the number of TB cases, the duration of infection in these cases, and the number of case contact interactions per unit of time.
Favorite
International Agencies
1999
This report discusses ways to reduce the spread and impact of infectious diseases, such as the six most deadly: HIV/AIDS, pneumonia, diarrhea, malaria, measles, and TB.
Favorite
International Agencies
1999
This report discusses the economic, psychological, and social impacts of TB and the strategies that households use to cope with them.
Favorite
International Agencies
2000
This report discusses the relationship between TB and sustainable development, and advocates for increased dialogue and action among TB partners.
Favorite
International Agencies
2000
This report describes World TB Day events and activities that took place on March 24, 2000 to raise public awareness about the extent of the TB epidemic in various countries and territories around the world.
Favorite
Community Leaders
International Agencies
2000
This fact sheet explains the purpose of the Global Drug Facility (GDF) to expand access to, and availability of, high-quality TB drugs to facilitate DOTS expansion, and to enable governments and nongovernmental organizations (NGOs) to implement effective TB control programs based upon the DOTS stragegy.
Favorite
International Agencies
2001
This prospectus is a culmination of input from Stop TB Partners including representatives from TB high-burden countries, UN agencies, Nongovernmental Organizations (NGOs), and foundations to develop the form, strategies, objectives, and governance of the Global TB Drug Facility (GDF).
Favorite
International Agencies
2001
This report presents information about the Global TB Drug Facility, a program designed to ensure access to and the availability of TB drugs.
Favorite
International Agencies
2001
This report discusses the burdens of AIDS, malaria, and TB; assesses the tools used to fight them; identifies barriers to success; and provides statistics on deaths caused by these diseases in 2000.
Favorite
International Agencies
Managers and Supervisors
2002
This document reinforces the five essential elements of the DOTS strategy.
Favorite
International Agencies
2002
This booklet answers questions about the 4-drug fixed-dose combinations containing 150 mg rifampicin, 75 mg isoniazid, 400 mg pyrazinamide, and 275 mg ethambutol that were added to the WHO Model List of Essential Drugs for the treatment of TB.
Favorite
International Agencies
2002
This group of four fact sheets explain the origin and purpose of the Global Drug Facility (GDF), how the GDF works, how to apply to the GDF for a grant of TB drugs, and how to buy drugs through the GDF.
Favorite
International Agencies
2002
This report explains the European DOTS Expansion plan to control TB. The plan highlights country needs and resource gaps, emphasizing collaboration with the governments of endemic countries, national and international agencies, and nongovernmental organizations (NGOs). The aim is to stimulate social and political commitment to achieving the global TB targets as part of the overall health system...
Favorite
International Agencies
Policy Makers
2002
This book presents five papers that were used as background to a workshop on "Improving TB Drug Management: Accelerating DOTS Expansion" on June 2002, in Washington, DC. The papers address the weaknesses in drug management programs of certain countries and provide a framework for strengthening these programs through country-specific action plans.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2002
This report discusses the global efforts of national education and advocacy events that occurred on World Tuberculosis (TB) Day 2002. The report provides information about campaigns that promoted TB prevention through socioeconomic change, government support, the formation of partnerships between governments and nongovernmental organizations (NGOs), and improved healthcare access and delivery.
Favorite
International Agencies
2002